Shiv  O'Neill net worth and biography

Shiv O'Neill Biography and Net Worth

Executive Vice President, General Counsel and Corporate Secretary of Elanco Animal Health

Shiv O’Neill serves as Executive Vice President, General Counsel and Corporate Secretary for Elanco. In this role, she is responsible for the global strategy and operations of our legal team, including commercial, intellectual property, regulatory legal, labor and employment, M&A and business development legal, and the office of the corporate secretary. She also oversees Elanco’s ethics & compliance and ESG matters.

In her previous role as VP, Deputy General Counsel - Americas for Elanco, Shiv led the strategy and operations of Elanco’s commercial and regulatory legal team in the Americas and provided strategic advice and counseling to company leaders within the U.S. Farm Animal, U.S. Pet Health and International businesses.

Prior to joining Elanco, Shiv served as Senior Counsel at Cummins Inc. During her tenure at Cummins, Shiv led critical matters in various areas, including global litigation, product safety, crisis management, internal investigations, and regulatory compliance, and served as counsel to Cummins subsidiary Zed Connect. Other leadership roles at Cummins include serving on the Product Safety Defect Board and the U.S. Legal Hiring Committee and leading the U.S. Pro Bono Committee. Before Cummins, Shiv was a partner at Faegre Baker Daniels LLP (now Faegre Drinker Biddle & Reath LLP), where she worked for 14 years and gained significant experience in litigation and transactional matters. Before joining Faegre Drinker, Shiv began her legal career at The Procter & Gamble Company.

Shiv was born in India and immigrated to the United States with her family as a child. She earned her undergraduate degree from Loyola University Chicago and her law degree from the Indiana University Maurer School of Law in Bloomington, Indiana. She has served on several boards of non-profit organizations and has been committed to pro bono work throughout her career.

What is Shiv O'Neill's net worth?

The estimated net worth of Shiv O'Neill is at least $2.12 million as of August 18th, 2026. Ms. O'Neill owns 87,832 shares of Elanco Animal Health stock worth more than $2,122,460 as of August 19th. This net worth estimate does not reflect any other assets that Ms. O'Neill may own. Learn More about Shiv O'Neill's net worth.

How do I contact Shiv O'Neill?

The corporate mailing address for Ms. O'Neill and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Shiv O'Neill's contact information.

Has Shiv O'Neill been buying or selling shares of Elanco Animal Health?

During the last ninety days, Shiv O'Neill has bought $94,272.84 in Elanco Animal Health stock. Most recently, on Tuesday, August 18th, Shiv O'neill bought 3,998 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $23.58 per share, with a total value of $94,272.84. Following the completion of the transaction, the insider now directly owns 87,832 shares of the company's stock, valued at $2,071,078.56. Learn More on Shiv O'Neill's trading history.

Who are Elanco Animal Health's active insiders?

Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), Paul Herendeen (Director), R. Hoover (Director), Lawrence Kurzius (Director), Rajeev Modi (Insider), Shiv O'Neill (Executive Vice President, General Counsel and Corporate Secretary), Jeffrey Simmons (President & CEO), Robert Vanhimbergen (CFO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.

Are insiders buying or selling shares of Elanco Animal Health?

During the last year, Elanco Animal Health insiders bought shares 10 times. They purchased a total of 76,530 shares worth more than $1,674,798.08. The most recent insider tranaction occured on August, 18th when insider Shiv O'neill bought 3,998 shares worth more than $94,272.84. Insiders at Elanco Animal Health own 1.1% of the company. Learn More about insider trades at Elanco Animal Health.

Information on this page was last updated on 8/18/2026.

Shiv O'Neill Insider Trading History at Elanco Animal Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/18/2026Buy3,998$23.58$94,272.8487,832View SEC Filing Icon  
See Full Table

Shiv O'Neill Buying and Selling Activity at Elanco Animal Health

This chart shows Shiv O'neill's buying and selling at Elanco Animal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elanco Animal Health Company Overview

Elanco Animal Health logo
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Read More

Today's Range

Now: $24.29
Low: $24.00
High: $24.57

50 Day Range

MA: $24.54
Low: $22.06
High: $26.48

2 Week Range

Now: $24.29
Low: $17.11
High: $27.98

Volume

1,401,728 shs

Average Volume

5,722,618 shs

Market Capitalization

$12.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67